Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review.
Level 2 - randomized trial
Systematic review including both clinical trials and observational studies without pooled meta-analysis
PubMed 36675177 · doi:10.3390/ijms24021659
What was done
The authors conducted a systematic review searching PubMed Central, Scopus, and Google Scholar to evaluate multi-therapeutic and personalized intervention programs for Alzheimer's disease (AD) and mild cognitive impairment (MCI). The review included clinical trials and observational studies investigating combinations of lifestyle, physical activity, mental activity, and nutritional or metabolic interventions.
What was found
The abstract reports no quantitative data, effect sizes, or study counts. It qualitatively reports that multi-factorial programs addressing metabolic abnormalities (such as insulin resistance, chronic inflammation, vitamin D deficiency, hormonal imbalances, and hyperhomocysteinemia) along with diet, sleep, and physical activity provide a rationale for managing the complex network dysfunction in AD and MCI beyond what single-drug therapies achieve.
Why it matters
This review aggregates evidence supporting comprehensive, multi-modal lifestyle and metabolic optimization programs rather than relying exclusively on mono-therapeutic pharmacological options for cognitive decline.
Limits
The abstract provides no quantitative outcomes, pooled statistical analyses, or specific counts of included studies and participants. The review incorporates observational studies alongside trials, increasing risk of confounding, and does not report standardized outcome comparisons across interventions.
Cited by
- context Recent research demonstrates that dementia can be reversed.